|
 |
 |
|
|
| Patent application |
Country |
| Novel vectors (GTU® Technology) |
Finland, PCT, USA, AP, AU, BR, CA, CN, CZ, EA, EE, EPO, HU, ID, IL, IN, JP, KR, MX, NZ, OA, PL, SG, SK, US, ZA |
| Medical Device (Device and gene therapy) |
Sweden, EPO (11 countries), USA, Australia, Canada, China, Japan, Hong Kong |
| Self-replicating vector for DNA immunization against HIV |
Finland, EPO, OAPI, India, Russia |
| VEGF |
USA, PCT |
| Superoxide dismutase |
Finland, PCT, Canada, EPO, Japan, New Zealand, USA |
| Anastomos |
Sweden, PCT |
| AIRE (immunological mechanisms) |
EPO, USA |
| DNMT3L (immune diseases, new gene) |
EPO, USA |
| Industrial kit (FITkit™) |
Finland (united with Diagnostic kit for foreign filings) |
| Diagnostic kit |
Finland (united with Industrial kit for foreign filings) |
| Industrial and diagnostic kit |
EPO, USA |
| Novel selection system |
Finland |
|
|
|
|
|
 |
|
|
|
 |
|
|
|
|
